Related Experiment Video
Updated: Jan 6, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Adsorptive therapy as a modificator for tumor-host interaction
L A Sakhno1, V V Sarnatskaya1, L A Yushko1
1R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of the NAS of Ukraine, Kyiv 03022, Ukraine.
Enterosorption (ES) using carbon adsorbents can mitigate paraneoplastic syndrome and reduce chemotherapy/radiation toxicity. This study shows ES suppresses metastasis, corrects anemia, and protects organs in cancer models.
Area of Science:
- Oncology
- Biomedical Engineering
- Toxicology
Background:
- Paraneoplastic syndrome (PNS) and systemic toxicity complicate cancer treatment.
- New generation carbon adsorbents offer potential for enterosorption (ES).
Purpose of the Study:
- To evaluate the efficacy of ES in managing PNS and treatment-related toxicities.
- To assess the impact of ES on tumor progression and organ function.
Main Methods:
- ES was administered to mice with Lewis lung carcinoma and rats with Guerin carcinoma.
- Effects on metastasis, anemia, bone marrow activity, organ histology, and blood markers were analyzed.
- ES was also tested in rats undergoing X-ray irradiation.
Main Results:
- ES significantly suppressed metastasis and corrected anemia in mice.
- ES improved kidney and liver function, reduced oxidative stress, and decreased endogenous intoxication.
- ES demonstrated nephroprotective effects against cisplatin toxicity and aided white blood cell restoration after irradiation.
Conclusions:
- Enterosorption with advanced carbon adsorbents shows significant potential in managing paraneoplastic syndrome and reducing chemo/radiotherapy toxicity.
- ES offers a promising adjunctive therapy for cancer patients, supporting organ function and immune recovery.
More Related Videos
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
The Tumor Microenvironment
Cell-mediated Immune Responses
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...